Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Shares Issued (2016 - 2025)

GeoVax Labs' Shares Issued history spans 12 years, with the latest figure at $3.0 million for Q4 2025.

  • Quarterly results put Shares Issued at $3.0 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $220.0 billion (up 9252394.51% YoY), and the annual figure for FY2025 was $18.9 million, up 699.46%.
  • Shares Issued for Q4 2025 was $3.0 million at GeoVax Labs, down from $220.0 billion in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $220.0 billion in Q3 2025 to a low of -$9.2 million in Q2 2022.
  • The 5-year median for Shares Issued is $3.0 million (2025), against an average of $20.0 billion.
  • Peak annual rise in Shares Issued hit 22500078.98% in 2025, while the deepest fall reached 371.41% in 2025.
  • Year by year, Shares Issued stood at -$6.0 million in 2021, then plummeted by 53.69% to -$9.2 million in 2022, then surged by 144.02% to $4.1 million in 2023, then plummeted by 75.93% to $977770.0 in 2024, then skyrocketed by 210.76% to $3.0 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $3.0 million, $220.0 billion, and -$3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.